Cite

HARVARD Citation

    Antaki, N. et al. (2013). IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4. Journal of viral hepatitis. 20 (1), pp. 59-64. [Online]. 
  
Back to record